Clean-label Ingredients Market to exceed $88.4 Bn by 2032, Says Global Market Insights Inc.
May 22, 2024 02:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, May 22, 2024 (GLOBE NEWSWIRE) -- The clean-label ingredients market valuation is predicted to cross USD 88.4 billion by the end of 2032, as reported in a research study by...
Notification de participation par BlackRock Inc.
May 22, 2024 02:30 ET
|
Syensqo SA
Notification de participation par BlackRock Inc. Bruxelles, Belgique – 22 mai 2024 - 8:30 CEST Conformément à la législation et réglementation en matière de transparence financière...
Participatiemelding van BlackRock Inc.
May 22, 2024 02:30 ET
|
Syensqo SA
Participatiemelding van BlackRock Inc. Brussel, België - 22 mei 2024 – 8u30 CEST In overeenstemming met de Belgische wetgeving op de openbaring van belangrijke deelnemingen (wet van 2...
Participation Notification by BlackRock Inc.
May 22, 2024 02:30 ET
|
Syensqo SA
Participation notification by BlackRock Inc. Brussels, Belgium – May 22, 2024 - 8:30 CEST According to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (12 Throgmorton...
Cornish Metals Increases Land Ownership at South Crofty Tin Project
May 22, 2024 02:00 ET
|
Cornish Metals Inc.
Cornish Metals has purchased approximately 7.7 acres of land located immediately adjacent to its 100% South Crofty Tin Project.
OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliques
May 22, 2024 01:30 ET
|
OSE Immunotherapeutics
OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliques...
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases
May 22, 2024 01:30 ET
|
OSE Immunotherapeutics
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases Nantes, France - Ingelheim, Germany - 22...
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe
May 22, 2024 01:00 ET
|
Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Wyost® (denosumab) and Jubbonti® (denosumab) approved by EC for all...
Predicine to Present 9 Liquid Biopsy Studies at ASCO 2024
May 22, 2024 00:11 ET
|
Predicine
HAYWARD, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Predicine, Inc. A leading precision oncology company, announced today that it will present data from 9 ctDNA studies at ASCO 2024, spotlighting the...
Oceana Calls on Coca-Cola’s Largest Bottler to Commit to Reuse and Plastic Reduction
May 22, 2024 00:00 ET
|
Oceana, Inc.
LONDON, May 22, 2024 (GLOBE NEWSWIRE) -- As shareholders of Coca-Cola Europacific Partners (CCEP) gather in London today for their annual meeting, Oceana will take to the surrounding streets,...